Trexquant Investment LP

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1633445 STAMFORD, CT

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$20,482,108

+$19,478,975 QoQ

Shares Held

83,679

+1309.9% QoQ

Ownership

0.160%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#82

of 494 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. AXSM ranks #4 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc. This page	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,482,108	83,679	+1309.9%	Shares	Sole	2026-08-14
2026-03-31	$1,003,133	5,935	-87.9%	Shares	Sole	2026-05-15
2025-12-31	$8,974,199	49,136	+416.1%	Shares	Sole	2026-02-17
2025-09-30	$1,156,325	9,521	-32.6%	Shares	Sole	2025-11-14
2024-12-31	$1,195,454	14,129	-19.0%	Shares	Sole	2025-02-12
2023-09-30	$1,219,580	17,450	-23.2%	Shares	Sole	2023-11-13
2023-03-31	$1,402,109	22,732	-5.1%	Shares	Sole	2023-05-15
2022-12-31	$1,847,649	23,955	+181.6%	Shares	Sole	2023-02-13
2021-12-31	$321,432	8,508	+30.6%	Shares	Sole	2022-02-14
2021-09-30	$214,734	6,515	-35.5%	Shares	Sole	2021-11-12
2020-06-30	$831,192	10,102	-65.3%	Shares	Sole	2020-08-07
2020-03-31	$1,713,129	29,120	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.